-
Tytuł:
-
The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.
-
Autorzy:
-
Dasgupta K; Divisions of General Internal Medicine, Clinical Epidemiology and Endocrinology, Department of Medicine, McGill University, McGill University Health Centre, Montreal, Québec, Canada. Electronic address: .
Quinn RR; Division of Nephrology, Department of Medicine, and Department of Community Health Sciences, Foothills Medical Centre, University of Calgary, Calgary, Alberta, Canada.
Zarnke KB; Division of General Internal Medicine, University of Calgary, Calgary, Alberta, Canada.
Rabi DM; Departments of Medicine, Community Health, and Cardiac Sciences, University of Calgary, Calgary, Alberta, Canada.
Ravani P; Division of Nephrology, Department of Medicine, and Department of Community Health Sciences, Foothills Medical Centre, University of Calgary, Calgary, Alberta, Canada.
Daskalopoulou SS; Divisions of General Internal Medicine, Clinical Epidemiology and Endocrinology, Department of Medicine, McGill University, McGill University Health Centre, Montreal, Québec, Canada.
Rabkin SW; Vancouver Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
Trudeau L; Division of Internal Medicine, McGill University, Montréal, Québec, Canada.
Feldman RD; Western University, London, Ontario, Canada.
Cloutier L; Université du Québec à Trois-Rivières, Trois-Rivières, Québec, Canada.
Prebtani A; McMaster University, Hamilton, Ontario, Canada.
Herman RJ; University of Calgary, Calgary, Alberta, Canada.
Bacon SL; Montreal Behavioural Medicine Centre, Concordia University and Hôpital du Sacré-Coeur de Montréal, Montréal, Québec, Canada.
Gilbert RE; University of Toronto, Division of Endocrinology, St Michael's Hospital, Toronto, Ontario, Canada.
Ruzicka M; Division of Nephrology, Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
McKay DW; Faculty of Medicine, Memorial University of Newfoundland, St John's, Newfoundland and Labrador, Canada.
Campbell TS; Department of Psychology, University of Calgary, Calgary, Alberta, Canada.
Grover S; Division of Clinical Epidemiology, Montreal General Hospital, Montreal, Québec, Canada.
Honos G; University of Montreal, Montreal, Québec, Canada.
Schiffrin EL; Department of Medicine and Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Québec, Canada.
Bolli P; Ambulatory Internal Medicine Teaching Clinic, St Catharines, Ontario, Canada.
Wilson TW; Department of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Lindsay P; Best Practices and Performance, Heart and Stroke Foundation, Toronto, Ontario, Canada.
Hill MD; Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
Coutts SB; Departments of Clinical Neurosciences and Radiology, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
Gubitz G; Division of Neurology, Halifax Infirmary, Dalhousie University, Halifax, Nova Scotia, Canada.
Gelfer M; Department of Family Medicine, University of British Columbia, Copeman Healthcare Centre, Vancouver, British Columbia, Canada.
Vallée M; Hôpital Maisonneuve-Rosemont, Université de Montréal, Montréal, Québec, Canada.
Prasad GV; University of Toronto, Toronto, Ontario, Canada.
Lebel M; Department of Medicine, l'Université Laval, Québec, Québec, Canada.
McLean D; University of Alberta, Edmonton, Alberta, Canada.
Arnold JM; Western University, London, Ontario, Canada.
Moe GW; St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
Howlett JG; Department of Medicine, University of Calgary, Calgary, Ontario, Canada.
Boulanger JM; Charles LeMoyne Hospital Research Centre, Sherbrooke University, Sherbrooke, Québec, Canada.
Larochelle P; Institut de recherches cliniques de Montréal, Université de Montréal, Montréal, Québec, Canada.
Leiter LA; Keenan Research Centre in the Li Ka Shing Knowledge Institute of St Michael's Hospital, and University of Toronto, Toronto, Ontario, Canada.
Jones C; Southern Medical Program, University of British Columbia, Okanagan Campus, Kelowna, British Columbia, Canada.
Ogilvie RI; University Health Network, Departments of Medicine and Pharmacology, University of Toronto, Toronto, Ontario, Canada.
Woo V; University of Manitoba, Winnipeg, Manitoba, Canada.
Kaczorowski J; Université de Montréal and CHUM, Montréal, Québec, Canada.
Burns KD; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Petrella RJ; Department of Family Medicine, Western University, London, Ontario, Canada.
Hiremath S; Division of Nephrology, University of Ottawa, Ottawa, Ontario, Canada.
Milot A; Department of Medicine, Université Laval, Québec, Québec, Canada.
Stone JA; Division of Cardiology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
Drouin D; Faculty of Medicine, Université Laval, Québec, Québec, Canada.
Lavoie KL; Department of Psychology, University of Québec at Montreal (UQAM), Montréal, Québec, Canada.
Lamarre-Cliche M; Institut de Recherches Cliniques de Montréal, Université de Montréal, Québec, Canada.
Tremblay G; CHU-Québec-Hopital St Sacrement, Québec, Québec, Canada.
Hamet P; Faculté de Médicine, Université de Montréal and Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.
Fodor G; University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Carruthers SG; Lisburn, Northern Ireland, UK.
Pylypchuk GB; Department of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Burgess E; Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada.
Lewanczuk R; University of Alberta, Edmonton, Alberta, Canada.
Dresser GK; Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Penner SB; Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Hegele RA; Departments of Medicine (Division of Endocrinology) and Biochemistry, Western University, London, Ontario, Canada.
McFarlane PA; Division of Nephrology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
Khara M; Vancouver Coastal Health Addiction Services, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Pipe A; Division of Prevention and Rehabilitation, University of Ottawa Heart Institute and University of Ottawa, Ottawa, Ontario, Canada.
Oh P; University Health Network, University of Toronto, Toronto, Ontario, Canada.
Selby P; Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada.
Sharma M; The Canadian Stroke Network, Ottawa, Ontario, Canada.
Reid DJ; Canadian Forces Health Services, Department of National Defence and Dietitians of Canada, Ottawa, Ontario, Canada.
Tobe SW; Northern Ontario School of Medicine, Greater Sudbury, Ontario, and University of Toronto, Toronto, Ontario, Canada.
Padwal RS; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Poirier L; Centre Hospitalier Universitaire de Québec et Faculté de Pharmacie, Université Laval, Québec, Québec, Canada.
-
Corporate Authors:
-
Canadian Hypertension Education Program
-
Źródło:
-
The Canadian journal of cardiology [Can J Cardiol] 2014 May; Vol. 30 (5), pp. 485-501. Date of Electronic Publication: 2014 Feb 22.
-
Typ publikacji:
-
Journal Article; Research Support, Non-U.S. Gov't; Review
-
Język:
-
English
-
Imprint Name(s):
-
Publication: Jan./Feb. 2011- : Oxford, UK : Elsevier
Original Publication: [Oakville, Ont. : Canadian Cardiology Publications Inc., c1984-
-
MeSH Terms:
-
Hypertension*/diagnosis
Hypertension*/drug therapy
Hypertension*/prevention & control
Patient Education as Topic*
Practice Guidelines as Topic*
Program Evaluation*
Antihypertensive Agents/*therapeutic use
Blood Pressure Determination/*standards
Health Promotion/*organization & administration
Blood Pressure ; Canada ; Humans ; Life Style ; Prognosis
-
Substance Nomenclature:
-
0 (Antihypertensive Agents)
-
Entry Date(s):
-
Date Created: 20140503 Date Completed: 20140624 Latest Revision: 20220408
-
Update Code:
-
20240104
-
DOI:
-
10.1016/j.cjca.2014.02.002
-
PMID:
-
24786438
-
Herein, updated evidence-based recommendations for the diagnosis, assessment, prevention, and treatment of hypertension in Canadian adults are detailed. For 2014, 3 existing recommendations were modified and 2 new recommendations were added. The following recommendations were modified: (1) the recommended sodium intake threshold was changed from ≤ 1500 mg (3.75 g of salt) to approximately 2000 mg (5 g of salt) per day; (2) a pharmacotherapy treatment initiation systolic blood pressure threshold of ≥ 160 mm Hg was added in very elderly (age ≥ 80 years) patients who do not have diabetes or target organ damage (systolic blood pressure target in this population remains at < 150 mm Hg); and (3) the target population recommended to receive low-dose acetylsalicylic acid therapy for primary prevention was narrowed from all patients with controlled hypertension to only those ≥ 50 years of age. The 2 new recommendations are: (1) advice to be cautious when lowering systolic blood pressure to target levels in patients with established coronary artery disease if diastolic blood pressure is ≤ 60 mm Hg because of concerns that myocardial ischemia might be exacerbated; and (2) the addition of glycated hemoglobin (A1c) in the diagnostic work-up of patients with newly diagnosed hypertension. The rationale for these recommendation changes is discussed. In addition, emerging data on blood pressure targets in stroke patients are discussed; these data did not lead to recommendation changes at this time. The Canadian Hypertension Education Program recommendations will continue to be updated annually.
(Copyright © 2014 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.)
